Related Experiment Video
Updated: Aug 14, 2026
12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan
Chih-Jung Chen1, Yhu-Chering Huang
1Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Children's Hospital, Taoyuan, Taiwan.
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is a growing concern, particularly community-acquired MRSA (CA-MRSA) in Taiwan. Sequence type 59 is the dominant CA-MRSA clone in northern Taiwan, showing unique resistance patterns.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Staphylococcus aureus, including methicillin-resistant strains (MRSA), causes significant hospital and community infections.
- Increasing antibiotic resistance, particularly to beta-lactams, complicates treatment.
- MRSA is transitioning from a nosocomial pathogen to a community-acquired threat.
Purpose of the Study:
- To investigate the characteristics of community-acquired MRSA (CA-MRSA) in Taiwan.
- To identify the predominant MRSA clones and their antibiotic resistance profiles.
- To explore the epidemiological link between community and healthcare-associated MRSA.
Main Methods:
- Multilocus sequence typing (MLST) was employed to determine the sequence types (STs) of MRSA isolates.
- Antibiotic susceptibility testing was performed for various non-beta-lactam antibiotics.
- Molecular epidemiology was used to trace MRSA transmission pathways.
Main Results:
- Sequence type 59 (ST59) was identified as the major clone of CA-MRSA in northern Taiwan.
- Taiwanese CA-MRSA isolates showed distinct characteristics, often lacking type IV SCCmec and exhibiting multi-drug resistance to clindamycin and macrolides.
- Evidence suggests the transmission of community MRSA strains into hospital settings, leading to healthcare-associated infections.
Conclusions:
- ST59 represents a significant CA-MRSA clone in Taiwan with unique genetic and resistance features.
- The findings highlight the emergence of CA-MRSA as a healthcare-associated pathogen.
- Treatment strategies for S. aureus infections should consider local epidemiology and resistance patterns.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:29Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...